Document is current
Any future updates will be listed below
-
Authors
Irisarri, Alba
Corral, Ana
Perez-Salvador, Núria
Bellver-Sanchis, Aina
Ribalta-Vilella, Marta
Bentanachs, Roger
Alegret, Marta
Laguna, Juan Carlos
Barroso, Emma
Palomer, Xavier
Ortuño-Sahagún, Daniel
Vázquez-Carrera, Manuel
Pallàs, Mercè
Herrero, Laura
Griñán-Ferré, Christian
-
Funding
Funding for this research was provided by:
Ministerio de Economía, Industria Economía, Industria y Competitividad (Agencia Estatal de Investigación, AEI) and European Union NextGenerationEU/PRTR (PID2021-122116OB-100, PDC2022-133441-I00, PID2020-114953RB-C21, PID2022-139016OA-I00)
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM)
the Government of Catalonia (2021 SGR 00357)
CIBEROBN (CB06/03/0001)
Carlos III Health Institute project and the Government of Catalonia (2021SGR00367)
Departament d’Empresa i Coneixement de la Generalitat de Catalunya 2023 (Producte 0092, Llavor 005 and 007)
- License Information
-
More Information
Article History
Received: 1 November 2024
Accepted: 12 February 2025
First Online: 21 February 2025
Declarations
:
: All procedures involving animals, including behavioral testing and dissection and removal of brains, followed ARRIVE and the standard ethical guidelines (Council of the European Communities Directive 2010/63/EU and Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research, National Research Council 2003) and were approved by the Institutional Animal Care and Generalitat de Catalunya (#10291, January 28, 2018). Every effort was made to minimize the number of mice used and their suffering.
: Not applicable.
: The authors declare no competing interests.
